Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Johannes Gutenberg-Universität Mainz

Saarstr. 21, 55099 Mainz
  • 6131/39-0
Forschungsprojekte
Ergebnisse pro Seite:  10

2016 - 2019

Daratumumab CUP (#660)
  • Dr. AlexanderDesuki

2016 - 2021

KALEIDOSCOPE (#625)
  • Prof. Dr. MarkusRadsak

2016 - 2019

SUSTAIN
  • PD Dr. JuliaWeinmann-Menke,
  • Univ.-Prof. Dr. AndreasSchwarting

2016 - 2017

VIOLET (17613): Efficacy and safety of three different Eylea regimens in subjects with DME
  • PD Dr. KatrinLorenz

2016 - 2018

BI 1320.22DME: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema
  • Dr. KatharinaBell,
  • PD Dr. KatrinLorenz

2016 - 2017

CAPTAIN (469055): Correlation of functional and structural outcomes with serum antibody profiles in patients with neovascular age-related macular degeneration treated with ranibizumab and healthy subjects: a prospective, controlled monocenter trial
  • Dr. ChristinaKorb

2016 - 2019

CA 209-473: A Multicenter, Randomized, Open-Label Study in Patients with Esophageal Cancer refractory or intolerant to Combination Therapy with Fluoropyrimidine and Platinum-based Drugs
  • Prof. Dr. MarkusMöhler

2016 - 2019

A Phase III, open-label, multicenter trial of avelumab (MSB00107118C) as a third-line treatment of unresectable, recurrent, or metastatic gastric or gastroesophageal junction adenocarcinoma
  • Prof. Dr. MarkusMöhler

2016 - 2018

STARflo MINIject
  • Univ.-Prof. Dr. NorbertPfeiffer,
  • PD Dr. KatrinLorenz

2016 - 2021

A Phase IIb/III prospective, randomized, double-blind, sham-controlled trail of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) in subjects with neurologic manifestations of Niemann-Pick Type C1 (NPC1) Disease
  • Univ.-Prof. Dr. Julia BeatriceHennermann,
  • Univ.-Prof. Dr. JörgFaber,
  • Prof. Dr. IreneKrämer